Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 54.7 | 0.0 | 44.7 | 0.0 | 0.0 | 0.0 |
| Revenue growth | | 22.5% | | | | | |
| Cost of goods sold | 0.0 | 76.5 | 0.0 | 64.8 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | -21.8 | 0.0 | -20.1 | 0.0 | 0.0 | 0.0 |
| Gross margin | | -39.8% | | -45.1% | | | |
| Research and development | 54.7 | | 44.7 | | 27.2 | 24.0 | 12.5 |
| General and administrative | 21.8 | 21.8 | 20.1 | 20.1 | 10.0 | 7.1 | 6.0 |
| EBIT | -76.5 | -76.5 | -64.8 | -64.8 | -37.2 | -31.2 | -18.6 |
| EBIT margin | | -139.8% | | -145.1% | | | |
| Pre-tax income | -77.4 | -77.4 | -64.8 | -64.8 | -48.3 | -30.7 | -18.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -77.4 | -77.4 | -64.8 | -64.8 | -56.8 | -35.0 | -18.1 |
| Net margin | | -141.4% | | -144.9% | | | |
| |
| Diluted EPS | ($2.99) | ($2.99) | ($2.56) | ($2.56) | ($9.35) | ($37.42) | ($22.88) |
| Shares outstanding (diluted) | 25.9 | 25.9 | 25.3 | 25.3 | 6.1 | 0.9 | 0.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|